|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01779 LONGBIO-B
Nominal 
130.900 -0.700 (-0.532%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (121,039) | (104,122) |
| Net Cash from / (used in) Investing Activities | -- | (57,141) | (45,556) |
| Net Cash from / (used in) Financing Activities | -- | 208,526 | 99,113 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 30,346 | (50,565) |
| Cash & Cash Equivalents at beginning of period | -- | 66,624 | 117,226 |
| Effect of Foreign Exchange Rate Changes | -- | (1,919) | (37) |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 95,051 | 66,624 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -134,808 |
| %Change | 43.096% |
| EPS / (LPS) | RMB -2.180 |
| NBV Per Share (¥) | RMB 15.193 |